Two Natural Cap is a research newsletter that analyses drug development and biotech markets, with recent issues covering gene editing, molecular glue degraders, and PROTAC-style protein degraders. Each issue combines mechanistic explanation with commercial context such as clinical data, competitive landscapes and big pharma deal activity.

A monthly pharma newsletter from consultancy Galenisys mixing first-person war stories from GMP auditing and quality work with short pieces on industry trends such as GLP-1 drugs and orexins. Readers get practical quality, contamination control and project management lessons alongside light market commentary.

Chivanta is a weekly Chinese-language newsletter by a former biotech industry professional who analyses the business side of life sciences, including business development, licensing, CDMO operations and market strategy. Recent issues mix practical lessons from industry work, such as backing research from market needs and estimating GMP manufacturing timelines and costs, with personal reflections.

Molecules & Empires examines how scientific breakthroughs such as AI-driven drug discovery, embryo gene editing and outbreak response reshape industries, economies and power. Its issues combine news hooks with analytical essays that weigh business strategy, ethics and science policy.